细胞毒性
线粒体
顺铂
癌细胞
自噬
癌症研究
细胞凋亡
NAD+激酶
药理学
小干扰RNA
线粒体ROS
细胞培养
化学
癌症
生物
体外
医学
转染
生物化学
化疗
内科学
酶
遗传学
作者
Sheng-Yi Lin,Jhih-Pu Syu,Yu‐Ting Lo,Yat‐Pang Chau,Ming‐Jaw Don,Horng-Tzer Shy,Shu-Mei Lai,Hsiu‐Ni Kung
出处
期刊:Phytomedicine
[Elsevier BV]
日期:2022-04-04
卷期号:101: 154094-154094
被引量:4
标识
DOI:10.1016/j.phymed.2022.154094
摘要
Cisplatin (CDDP) is a first-line chemotherapeutic drug for treating various cancers. However, CDDP also damages normal cells and causes many side effects. Recently, CDDP has been demonstrated to kill cancer cells by targeting mitochondria. Protecting mitochondria might be a potential therapeutic strategy for CDDP-induced side effects. β -Lapachone ( β -lap), a recognized NAD + booster, has been reported to regulate mitochondrial activity. However, it remains unclear whether maintaining mitochondrial activity is the key factor in the protective effects of β -lap in CDDP-treated normal cells. In this study, the protective effects of β -lap on mitochondria against CDDP cytotoxicity in normal cells were evaluated. In vitro cell models were used in this study, including 3T3 fibroblasts, human dermal fibroblasts, MCF-7 breast cancer cells, and MDA-MB-231 breast cancer cells. Cells were treated with CDDP and β -lap, and cell survival, NAD + , mitochondrial activity, autophagy, and ATP production were measured. Various inhibitors and siRNAs were used to confirm the key signal underlying the protective effects of β -lap. The results demonstrated that β -lap significantly decreased CDDP cytotoxicity in normal fibroblasts. With various inhibitors and siRNAs, β -lap reduced CDDP-induced damage to normal fibroblasts by maintaining mitochondrial activity and increasing autophagy through the NQO1/NAD + /SIRT1 axis. Most importantly, the protective effects of β -lap in fibroblasts did not affect the therapeutic effects of CDDP in cancer cells. This study indicated that mitochondrial activity, energy production, and NQO1 levels might be crucial responses separating normal cells from cancer cells under exposure to CDDP and β -lap. β -lap could be a good synergistic drug for reducing the side effects of CDDP without affecting the anticancer drug effect.
科研通智能强力驱动
Strongly Powered by AbleSci AI